Zobrazeno 1 - 10
of 733
pro vyhledávání: '"Lyso gb3"'
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 11, p1531-1537, 7p
Publikováno v:
Korean Journal of Physiology & Pharmacology. May2023, Vol. 27 Issue 3, p231-240. 10p.
Autor:
Sueoka, Hideaki1, Ichihara, Junji2, Tsukimura, Takahiro3, Togawa, Tadayasu3, Sakuraba, Hitoshi4 sakuraba@my-pharm.ac.jp
Publikováno v:
PLoS ONE. May2015, Vol. 10 Issue 5, p1-13. 13p.
Autor:
Kämpf, Tanja
Der Morbus Fabry ist eine sehr heterogenetische und heterophänotypische Krankheit. Ursache der Erkrankung liegt in der Mutation des alpha- Galaktosidase Gens. Es kommt zur Akkumulation von Glykosphingolipiden. Man kann den klassischen Typ von mehrer
Autor:
Rombach, Saskia M.1, Aerts, Johannes M. F. G.2, Poorthuis, Ben J. H. M.2, Groener, Johanna E. M.2, Donker-Koopman, Wilma2, Hendriks, Erik2, Mirzaian, Mina2, Kuiper, Sijmen2, Wijburg, Frits A.2, Hollak, Carla E. M.1, Linthorst, Gabor E.1 g.e.linthorst@amc.nl
Publikováno v:
PLoS ONE. Oct2012, Vol. 7 Issue 10, Special section p1-7. 7p.
Autor:
Aneal Khan, Christiane Auray-Blais, Mark R. Iwanochko, Daniel G. Bichet, Michael West, Kaye LeMoine, Sandra Sirrs
Publikováno v:
Molecular Genetics and Metabolism. 132:S111
Autor:
Saskia M Rombach, Johannes M F G Aerts, Ben J H M Poorthuis, Johanna E M Groener, Wilma Donker-Koopman, Erik Hendriks, Mina Mirzaian, Sijmen Kuiper, Frits A Wijburg, Carla E M Hollak, Gabor E Linthorst
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47805 (2012)
IntroductionEnzyme replacement therapy (ERT) with alpha-Galactosidase A (aGal A) may cause antibody (AB) formation against aGal A in males with Fabry disease (FD). Anti agalsidase ABs negatively influence globotriaosylceramide (Gb3) reduction. We inv
Externí odkaz:
https://doaj.org/article/430552f7237642d1bf77438f9ca510a1
Autor:
Auray-Blais, Christiane, Lavoie, Pamela, Martineau, Tristan, Ntumba, Georges Kabala, Gamrani, Mohamed, Khan, Aneal, Altarescu, Gheona, Lehman, Anna, Goker-Alpan, Ozlem, Nowak, Albina, West, Michael L, Bichet, Daniel G
Publikováno v:
Bioanalysis; Dec2023, Vol. 15 Issue 23, p1421-1437, 17p
Autor:
Sueoka, Hideaki1, Aoki, Mikio1, Tsukimura, Takahiro2, Togawa, Tadayasu2, Sakuraba, Hitoshi3 sakuraba@my-pharm.ac.jp
Publikováno v:
PLoS ONE. 12/14/2015, Vol. 10 Issue 12, p1-11. 11p.
Autor:
Hao-Chuan Liu1,2 sleeper992@yahoo.com.tw, Hsiang-Yu Lin3,4,5,6 lxc46199@ms37.hinet.net, Chia-Feng Yang1 pum_chia@yahoo.com.tw, Hsuan-Chieh Liao3,7 liaojoyce@cfoh.org.tw, Ting-Rong Hsu1,3 romberg@gmail.com, Chiao-Wei Lo8 weii0621@gmail.com, Fu-Pang Chang9 orimiltea@gmail.com, Chun-Kai Huang1 gavin0402@gmail.com, Yung-Hsiu Lu1,2,3 sugar1102@gmail.com, Shuan-Pei Lin4,5,6 zsplin14@gmail.com, Wen-Chung Yu2,10,11 wcyu@vghtpe.gov.tw, Dau-Ming Niu1,2,3 dmniu1111@yahoo.com.tw
Publikováno v:
Orphanet Journal of Rare Diseases. 2014, Vol. 9 Issue 1, p1-20. 20p.